238 related articles for article (PubMed ID: 30850186)
1. New Advances of Heparanase and Heparanase-2 in Human Diseases.
Jin H; Cui M
Arch Med Res; 2018 Oct; 49(7):423-429. PubMed ID: 30850186
[TBL] [Abstract][Full Text] [Related]
2. The Functions of Heparanase in Human Diseases.
Jin H; Zhou S
Mini Rev Med Chem; 2017; 17(6):541-548. PubMed ID: 27804885
[TBL] [Abstract][Full Text] [Related]
3. New Advances of Heparanase in Human Diseases.
Jin H; Cui M
Mini Rev Med Chem; 2020; 20(2):90-95. PubMed ID: 31518222
[TBL] [Abstract][Full Text] [Related]
4. New findings of heparanase in human diseases.
Jin H; Cui M; Hu SX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5999-6004. PubMed ID: 31298354
[TBL] [Abstract][Full Text] [Related]
5. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
6. Heparanase as a target in cancer therapy.
Masola V; Secchi MF; Gambaro G; Onisto M
Curr Cancer Drug Targets; 2014; 14(3):286-93. PubMed ID: 24568197
[TBL] [Abstract][Full Text] [Related]
7. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
8. Implications of heparan sulfate and heparanase in neuroinflammation.
Zhang X; Wang B; Li JP
Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
[TBL] [Abstract][Full Text] [Related]
9. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.
Goodall KJ; Poon IK; Phipps S; Hulett MD
PLoS One; 2014; 9(10):e109596. PubMed ID: 25295599
[TBL] [Abstract][Full Text] [Related]
10. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
11. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
[TBL] [Abstract][Full Text] [Related]
12. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
14. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.
Secchi MF; Masola V; Zaza G; Lupo A; Gambaro G; Onisto M
Biomol Concepts; 2015 Dec; 6(5-6):415-21. PubMed ID: 26552066
[TBL] [Abstract][Full Text] [Related]
15. Multi-faceted substrate specificity of heparanase.
Peterson SB; Liu J
Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
[TBL] [Abstract][Full Text] [Related]
16. [Research advancement on heparanase in tumor metastasis].
Li ZH; Yang SM
Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
[TBL] [Abstract][Full Text] [Related]
17. Heparanase Inhibitors in Cancer Progression: Recent Advances.
Kaur R; Deb PK; Diwan V; Saini B
Curr Pharm Des; 2021; 27(1):43-68. PubMed ID: 33185156
[TBL] [Abstract][Full Text] [Related]
18. Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.
Vlodavsky I; Barash U; Nguyen HM; Yang SM; Ilan N
Semin Thromb Hemost; 2021 Apr; 47(3):240-253. PubMed ID: 33794549
[TBL] [Abstract][Full Text] [Related]
19. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
Chhabra M; Ferro V
Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
[TBL] [Abstract][Full Text] [Related]
20. Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.
Rabelink TJ; van den Berg BM; Garsen M; Wang G; Elkin M; van der Vlag J
Nat Rev Nephrol; 2017 Apr; 13(4):201-212. PubMed ID: 28163306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]